Real Talk

Only 15 to 20 Pounds to Lose? How GLP-1 Eligibility Actually Works After 40

Dr. SkinnyVIP October 4, 2026 ~7 min read
The short version
Clinicians don’t decide GLP-1 eligibility by how many pounds you want to lose. FDA labeling for brand-name GLP-1s is based on BMI and weight-related health conditions, and a licensed clinician weighs your full history. Some women with a modest goal qualify and some don’t. The only way to know for sure is a clinician review.

Why this question comes up so often after 40

Here’s a conversation we hear constantly. “I’m not trying to lose 80 pounds. I’m otherwise healthy. I just have 15 or 20 pounds that showed up in my forties and won’t leave, no matter what I do. Is a GLP-1 even for someone like me?”

It’s a fair question, and the honest answer is: it depends, and not on the number you have in mind. Many women in their 40s and 50s notice that the scale has moved only modestly while their waistline, energy, and lab numbers have changed more. That’s not imagined. A study in Scientific Reports found that for a given total fat mass, postmenopausal women stored significantly more visceral fat (the fat around the organs) than premenopausal women.

So “only 15 pounds” can mean very different things for two different women. That’s exactly why clinicians look past the number.

What the FDA criteria actually say

When the FDA approved brand-name Zepbound (tirzepatide) for chronic weight management, it was for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition, such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea. Brand-name Wegovy (semaglutide) uses the same BMI framework.

For a sense of scale: a woman who is 5′4″ and weighs 165 pounds has a BMI of about 28. At that BMI, the FDA framework for the brand-name products looks for at least one weight-related condition. The same woman at 185 pounds has a BMI of about 32.

Compounded medications are different. Compounded tirzepatide is not an FDA-approved product, and it is prepared by licensed compounding pharmacies under physician supervision. Whether it’s appropriate for you is a clinical judgment made by a licensed clinician based on your history, not a rule you can look up in a chart.

Why “pounds to lose” isn’t the measure

BMI itself is a screening tool, not a verdict. As a National Academies workshop summary puts it, BMI is used to screen for obesity, but it does not displace clinical judgment, and it is not a direct measure of body fat.

That’s why a licensed clinician looks at the whole picture, including:

The pounds-to-lose number tells a clinician what you want. Everything else tells them whether treatment makes sense.

7 questions to ask a licensed clinician

If you have a modest goal and you’re considering a GLP-1, these are the questions worth asking before anyone writes a prescription:

  1. Based on my BMI and history, am I a candidate at all? Ask for the reasoning, not just a yes or no.
  2. Do I have a weight-related condition that matters here? Blood pressure, cholesterol, or blood sugar results can change the answer.
  3. Is there anything in my history that rules this out? Certain personal or family history makes GLP-1 medications inappropriate.
  4. How will we protect muscle? After 40, losing weight without losing strength takes a plan. See our guide on preventing muscle loss on tirzepatide.
  5. What side effects should I expect, and when should I call? Our side effects after 40 guide covers the common ones.
  6. How will we decide when I’ve reached my goal? Agree up front on what “done” or “maintenance” looks like.
  7. What’s the total cost, and does anything bill automatically? A modest goal shouldn’t come with an open-ended subscription.

That last question matters more than people expect. If your goal is modest, a program built around a long recurring membership may not fit. Ask exactly what you’ll be charged, and when.

Not sure you qualify?
Let a licensed clinician decide. Full refund if not prescribed.

$695 for 3 months (about $232/month) or $350 for 1 month, any dose. No membership, no subscription, no auto-billing.

Start Your Consultation

How it works at SkinnyVIP

You complete a secure online intake covering your health history, medications, and goals. A licensed clinician reviews it and decides whether compounded tirzepatide is clinically appropriate for you. SkinnyVIP does not itself prescribe, and a prescription is not guaranteed.

If the clinician decides treatment isn’t right for you, you’re refunded in full, provided your intake information was accurate and complete. That takes the risk out of asking the question. You find out from a clinician instead of guessing from a BMI chart.

If you are prescribed, the price is the same at every dose: $695 for a 3-month plan or $350 for a single month. Nothing renews automatically, which suits a modest, defined goal. You can compare how other programs price this on our GLP-1 Telehealth Real-Price Index.

If the answer is no

A “no” isn’t a dead end. It usually means a GLP-1 isn’t the right tool for you right now. Plenty of women with a modest goal get the most from changes that rarely get credit after 40: steady protein, strength training, better sleep, and, where appropriate, talking with a clinician about perimenopause or menopause symptoms. Our guide to weight changes in perimenopause and menopause is a good place to start.

Compounded medications are not FDA-approved products. They are prepared by licensed compounding pharmacies under physician supervision. Individual results vary.

Find out if you qualify, without the risk

A licensed clinician reviews your intake. If treatment isn’t appropriate, you’re refunded in full. Telemedicine is available nationwide, subject to state-by-state licensure.

Start Your Consultation How Compounded Tirzepatide Works

SkinnyVIP does not itself prescribe; prescription is not guaranteed. Individual results vary.

Keep Reading

Clinical
How to Prevent Muscle Loss on Tirzepatide After 40
Clinical
GLP-1 Side Effects After 40: What’s Common, What’s Not
Clinical
What the First Month on a GLP-1 Can Feel Like

Sources

  1. U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management. fda.gov
  2. National Academies of Sciences, Engineering, and Medicine. The Science, Strengths, and Limitations of Body Mass Index. ncbi.nlm.nih.gov
  3. Scientific Reports. Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass. nature.com
Frequently Asked Questions

GLP-1 Eligibility FAQ

Starting points only. A licensed clinician makes the decision based on your full history.

Can I get a GLP-1 if I only have 15 to 20 pounds to lose?

Possibly. Pounds to lose is not the standard clinicians use. FDA labeling for brand-name GLP-1s is based on BMI and weight-related health conditions, and a licensed clinician weighs your full history. Some people with a modest goal meet the criteria and some do not. Intake is how you find out.

What BMI do you need to qualify for tirzepatide?

FDA approved brand-name Zepbound for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure. Compounded tirzepatide is not FDA-approved, and a licensed clinician decides whether it is clinically appropriate for you.

Is a GLP-1 safe if I'm otherwise healthy?

Being otherwise healthy is a good starting point, but it is not a yes on its own. A licensed clinician reviews your medical history, current medications, and personal or family history of certain conditions before deciding. GLP-1 medications have known side effects and are not right for everyone.

What happens if the clinician says I'm not a candidate?

At SkinnyVIP, if the licensed clinician determines treatment is not appropriate for you, you receive a full refund, provided your intake information was accurate and complete. You are never charged for medication you are not prescribed, and you can ask the clinician what else might help.

How much does SkinnyVIP cost if I do qualify?

SkinnyVIP charges $695 for a 3-month plan, about $232 per month, or $350 for a single month. The price is the same at every dose from 2.5 to 15 mg per week. There is no membership, no subscription, and no auto-billing.

This article is educational and is not medical advice. Not affiliated with Novo Nordisk (Ozempic®/Wegovy®) or Eli Lilly (Mounjaro®/Zepbound®). Compounded medications are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved products. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. SkinnyVIP does not itself prescribe. A licensed clinician reviews each patient; prescription is not guaranteed. Individual results vary.